...
首页> 外文期刊>Journal of the European Academy of Dermatology and Venereology: JEADV >In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5‐fluorouracil
【24h】

In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5‐fluorouracil

机译:在体内共聚焦激光显微镜下监测活性角化症治疗:用局部5%5-氟尿嘧啶治疗后组织病理学评估的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background Histological examination is the gold standard for actinic keratosis diagnosis; however, it is not always a feasible approach. Reflectance confocal microscopy (RCM) is a non‐invasive technique that may be an alternative for monitoring actinic keratoses treatment response. Topical 5‐fluorouracil is indicated for actinic keratosis multiple lesions and for field cancerization treatment. Objectives To assess the RCM accuracy, sensibility and specificity for actinic keratosis, considering as a gold standard the histopathological examination; as well as to evaluate the efficacy of 5% 5‐fluorouracil treatment. Methods This is a prospective study in actinic keratosis patients between August 2014 and November 2015. RCM analyses were performed in one randomly selected actinic keratosis lesion of the upper limbs by two independent observers before and after 5% 5‐fluorouracil treatment. At the end of treatment and with clinical bleaching of treated lesions, histological examination was performed by two pathologists. Results A total of 50 lesions were enroled, and 40 lesions presented complete clinical bleaching after treatment and were included in the final analysis. Accuracy, sensibility and specificity means among observers were 83.8%, 84.6% and 83.3%, respectively. After 5‐fluorouracil treatment, actinic keratosis was diagnosed in 45.0% (observer 1) and 32.5% (observer 2) of subjects according to RCM and in 32.5% of subjects according to histological examination. Considering RCM observers diagnosis, the concordance was substantial ( k 0.637, P ??0.001). 5‐fluorouracil led to a reduction in 55.0%–67.5% of actinic keratoses according to RCM analysis. Conclusion This study allows to validate RCM as a non‐invasive method capable of monitoring actinic keratosis therapeutic response to 5‐fluorouracil, presenting efficacy comparable to histological examination. Additionally, the results suggest that 5‐fluorouracil may be a satisfactory option for therapeutic control of this condition.
机译:摘要背景技术组织学检查是活性角化症诊断的金标。但是,它并不总是一种可行的方法。反射率共聚焦显微镜(RCM)是一种非侵入性技术,可以是监测光化角质治疗响应的替代方案。局部5-氟尿嘧啶用于光化角膜病多个病变和用于现场癌症治疗。目的是评估光学角化症的RCM精度,敏感性和特异性,考虑到组织病理学检查的黄金标准;除了评价5%5-氟尿嘧啶处理的功效。方法是2014年8月至2015年8月至11月在2015年8月至11月期间的一项前瞻性研究。在5%5-氟尿嘧啶治疗之前和之后,通过两次独立的观察者随机选择的中肢的随机选择的光碱角化病变进行RCM分析。在治疗结束时和治疗病变的临床漂白,两位病理学家进行组织学检查。结果总共有50个病变,40例病变在治疗后呈现完整的临床漂白,并包含在最终分析中。观察者的准确性,敏感性和特异性分别为83.8%,84.6%和83.3%。在5-氟尿嘧啶处理后,根据RCM和32.5%的受试者,在45.0%(观察者1)和32.5%(观察者2)中,根据组织学检查,诊断为45.0%(观察者1)和32.5%(观察者2)。考虑到RCM观察者的诊断,一致性很大(K 0.637,p≤≤0.001)。根据RCM分析,5氟尿嘧啶导致55.0%-67.5%的活化角膜。结论本研究允许验证RCM作为能够监测到5-氟尿嘧啶的光化角瘤治疗反应的非侵入性方法,呈现与组织学检查相当的疗效。另外,结果表明,5-氟尿嘧啶可能是对这种情况治疗控制的令人满意的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号